IBDEI0CG ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16836,0)
 ;;=V10.04^^107^1079^62
 ;;^UTILITY(U,$J,358.3,16836,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16836,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,16836,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,16836,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,16837,0)
 ;;=V10.47^^107^1079^63
 ;;^UTILITY(U,$J,358.3,16837,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16837,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,16837,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,16837,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,16838,0)
 ;;=V10.83^^107^1079^61
 ;;^UTILITY(U,$J,358.3,16838,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16838,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,16838,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,16838,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,16839,0)
 ;;=285.22^^107^1079^7
 ;;^UTILITY(U,$J,358.3,16839,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16839,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,16839,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,16839,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,16840,0)
 ;;=285.21^^107^1079^8
 ;;^UTILITY(U,$J,358.3,16840,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16840,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,16840,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,16840,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,16841,0)
 ;;=285.29^^107^1079^9
 ;;^UTILITY(U,$J,358.3,16841,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16841,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,16841,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,16841,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,16842,0)
 ;;=284.9^^107^1079^10
 ;;^UTILITY(U,$J,358.3,16842,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16842,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,16842,1,5,0)
 ;;=5^Aplastic Anemia Nos
 ;;^UTILITY(U,$J,358.3,16842,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,16843,0)
 ;;=282.61^^107^1079^66
 ;;^UTILITY(U,$J,358.3,16843,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16843,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,16843,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,16843,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,16844,0)
 ;;=282.7^^107^1079^65
 ;;^UTILITY(U,$J,358.3,16844,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16844,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,16844,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,16844,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,16845,0)
 ;;=283.9^^107^1079^68
 ;;^UTILITY(U,$J,358.3,16845,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16845,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,16845,1,5,0)
 ;;=5^Hemolytic Anemia , Acquired
 ;;^UTILITY(U,$J,358.3,16845,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,16846,0)
 ;;=283.0^^107^1079^69
 ;;^UTILITY(U,$J,358.3,16846,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16846,1,4,0)
 ;;=4^283.0
 ;;^UTILITY(U,$J,358.3,16846,1,5,0)
 ;;=5^Hemolytic Anemia, Autoimmune
 ;;^UTILITY(U,$J,358.3,16846,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,16847,0)
 ;;=282.9^^107^1079^67
 ;;^UTILITY(U,$J,358.3,16847,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16847,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,16847,1,5,0)
 ;;=5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,16847,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,16848,0)
 ;;=283.19^^107^1079^70
 ;;^UTILITY(U,$J,358.3,16848,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16848,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,16848,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,16848,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,16849,0)
 ;;=280.9^^107^1079^74
 ;;^UTILITY(U,$J,358.3,16849,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16849,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,16849,1,5,0)
 ;;=5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,16849,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,16850,0)
 ;;=285.1^^107^1079^72
 ;;^UTILITY(U,$J,358.3,16850,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16850,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,16850,1,5,0)
 ;;=5^Iron Defic Anemia Due To Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,16850,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,16851,0)
 ;;=280.0^^107^1079^73
 ;;^UTILITY(U,$J,358.3,16851,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16851,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,16851,1,5,0)
 ;;=5^Iron Defic Anemia Due To Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,16851,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,16852,0)
 ;;=281.9^^107^1079^92
 ;;^UTILITY(U,$J,358.3,16852,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16852,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,16852,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,16852,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,16853,0)
 ;;=281.0^^107^1079^109
 ;;^UTILITY(U,$J,358.3,16853,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16853,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,16853,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,16853,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,16854,0)
 ;;=282.60^^107^1079^99
 ;;^UTILITY(U,$J,358.3,16854,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16854,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,16854,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,16854,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,16855,0)
 ;;=282.62^^107^1079^100
 ;;^UTILITY(U,$J,358.3,16855,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16855,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,16855,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,16855,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,16856,0)
 ;;=281.1^^107^1079^110
 ;;^UTILITY(U,$J,358.3,16856,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16856,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,16856,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,16856,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,16857,0)
 ;;=286.7^^107^1079^44
 ;;^UTILITY(U,$J,358.3,16857,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16857,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,16857,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,16857,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,16858,0)
 ;;=289.9^^107^1079^106
 ;;^UTILITY(U,$J,358.3,16858,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16858,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,16858,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,16858,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,16859,0)
 ;;=451.9^^107^1079^107
 ;;^UTILITY(U,$J,358.3,16859,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16859,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,16859,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,16859,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,16860,0)
 ;;=446.6^^107^1079^108
 ;;^UTILITY(U,$J,358.3,16860,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16860,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,16860,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(Ttp)
 ;;^UTILITY(U,$J,358.3,16860,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,16861,0)
 ;;=286.4^^107^1079^111
 ;;^UTILITY(U,$J,358.3,16861,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16861,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,16861,1,5,0)
 ;;=5^Von Willebrand'S Disease
 ;;^UTILITY(U,$J,358.3,16861,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,16862,0)
 ;;=204.00^^107^1079^4
 ;;^UTILITY(U,$J,358.3,16862,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16862,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,16862,1,5,0)
 ;;=5^All, W/O Remission
 ;;^UTILITY(U,$J,358.3,16862,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,16863,0)
 ;;=204.01^^107^1079^3
 ;;^UTILITY(U,$J,358.3,16863,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16863,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,16863,1,5,0)
 ;;=5^All, In Remission
 ;;^UTILITY(U,$J,358.3,16863,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,16864,0)
 ;;=204.10^^107^1079^41
 ;;^UTILITY(U,$J,358.3,16864,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16864,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,16864,1,5,0)
 ;;=5^Cll, W/O Remission
 ;;^UTILITY(U,$J,358.3,16864,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,16865,0)
 ;;=204.11^^107^1079^40
 ;;^UTILITY(U,$J,358.3,16865,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16865,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,16865,1,5,0)
 ;;=5^Cll, In Remission
 ;;^UTILITY(U,$J,358.3,16865,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,16866,0)
 ;;=201.90^^107^1079^71
 ;;^UTILITY(U,$J,358.3,16866,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16866,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,16866,1,5,0)
 ;;=5^Hodgkin'S Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,16866,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,16867,0)
 ;;=785.6^^107^1079^77
 ;;^UTILITY(U,$J,358.3,16867,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16867,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,16867,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,16867,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,16868,0)
 ;;=200.20^^107^1079^78
 ;;^UTILITY(U,$J,358.3,16868,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16868,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,16868,1,5,0)
 ;;=5^Lymphoma, Burkitt'S, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,16868,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,16869,0)
 ;;=202.00^^107^1079^80
 ;;^UTILITY(U,$J,358.3,16869,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16869,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,16869,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,16869,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,16870,0)
 ;;=200.10^^107^1079^79
 ;;^UTILITY(U,$J,358.3,16870,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16870,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,16870,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,16870,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,16871,0)
 ;;=273.3^^107^1079^81
 ;;^UTILITY(U,$J,358.3,16871,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16871,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,16871,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,16871,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,16872,0)
 ;;=203.00^^107^1079^90
 ;;^UTILITY(U,$J,358.3,16872,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16872,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,16872,1,5,0)
 ;;=5^Multiple Myeloma W/O Rem
